Basics Larimar Therapeutics, Inc. Common Stock IPO Date: July 1, 2014 Sector: Healthcare Industry: Biotech Market Cap: $202.33M Activated in VL: True Average Daily Range Avg Daily Range: $0.29 | 3.84% Avg Daily Range (30 D): $0.13 | 4.20% Avg Daily Range (90 D): $0.12 | 4.74% Institutional Daily Volume Avg Daily Volume: .13M Avg Daily Volume (30 D): 1.03M Avg Daily Volume (90 D): 1.07M Trade Size Avg Trade Size (Sh.): 114 Avg Trade Size (Sh.) (30 D): 155 Avg Trade Size (Sh.) (90 D): 160 Institutional Trades Total Inst.Trades: 166 Avg Inst. Trade: $1.71M Avg Inst. Trade (30 D): $1.4M Avg Inst. Trade (90 D): $1.05M Avg Inst. Trade Volume: .23M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.98M Avg Closing Trade (30 D): $1.08M Avg Closing Trade (90 D): $.99M Avg Closing Volume: 303.07K     News Sep 19, 2024 @ 11:00 AM Larimar Therapeutics Announces Three Poster Presen... Source: N/A May 29, 2024 @ 12:45 PM 2 Potentially High-Reward Growth Stocks to Buy Rig... Source: newsfeedback@fool.com (George Budwell) May 24, 2024 @ 1:38 PM The Zacks Analyst Blog Highlights Biogen, Ionis Ph... Source: Zacks Equity Research May 23, 2024 @ 4:46 PM Biotech Stock Roundup: BIIB's Acquisition, PTCT, L... Source: Zacks Equity Research May 22, 2024 @ 3:25 PM Larimar (LRMR) Up on Lifting of Partial Clinical H... Source: Zacks Equity Research Financials   TTM Q1 2025 Q4 2024 Basic EPS $-1.5 $-.46 $-.46 Diluted EPS $-1.5 $-.46 $-.46 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -95.23M $ -29.28M $ -28.82M Operating Income / Loss $ -105.34M $ -31.19M $ -31.29M Cost of Revenue $ $ $ Net Cash Flow $ -77.64M $ M $ -2.58M PE Ratio